Rapid Nutrition Accelerates Completion of ACM Convertible Bond Agreement

18 Jun 2025 04:30 CEST

Rapid Nutrition Accelerates Completion of ACM  Convertible Bond Agreement

Company concludes note conversion six months ahead of schedule, reinforcing financial stability and strategic progress

London, United Kingdom – 18 June 2025 – Rapid Nutrition PLC (Euronext Growth: ALRPD), an international HealthTech and wellness company, is pleased to announce the early redemption and conversion of its convertible bond agreement with ACM, which was originally expected to take up to 12 months to complete. Thanks to substantial progress made during the first half of the year, the Company has successfully concluded the agreement in just six months.

This early completion marks a meaningful step forward in Rapid Nutrition’s ongoing efforts to strengthen its capital structure and optimise shareholder alignment. The accelerated conclusion reflects the Company’s continued focus on financial discipline and operational execution across its global footprint, including key markets such as China, the United States, and Europe.

Simon St. Ledger, CEO of Rapid Nutrition, commented:
"Bringing the ACM convertible note agreement to a close well ahead of schedule is a clear reflection of the momentum we’ve built in the first half of the year. This provides us with greater flexibility and a stronger foundation to pursue our long-term growth strategy with confidence.”

The Company extends its appreciation to ACM for its continued support and remains focused on expanding its global presence, delivering innovation, and creating sustainable value for all stakeholders.

About Rapid Nutrition

Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.

Investor Relations Contact:

ir@rnplc.com

Disclaimer

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).